NCT03588325

Brief Summary

The purpose of this study is to confirm the clinical validity and the performance of the Monocyte Width Distribution (MDW) parameter to detect the development of sepsis in a prospective study of Emergency Department (ED) adults who have blood draw including Complete Blood Count with differential (CBC-DIFF) ordered upon presentation in a Spanish \& French hospital and to verify cut-off for Tri-potassium ethylenediaminetetraacetic acid (K3EDTA).

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
947

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2018

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 17, 2018

Completed
22 days until next milestone

Study Start

First participant enrolled

August 8, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2019

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
Last Updated

November 22, 2019

Status Verified

November 1, 2019

Enrollment Period

12 months

First QC Date

July 6, 2018

Last Update Submit

November 21, 2019

Conditions

Keywords

MDWSepsis

Outcome Measures

Primary Outcomes (1)

  • Identification of sepsis based on Sepsis-2 criteria

    Determination of diagnostic accuracy based on Receiver Operating Characteristic Curves

    Within 4 hours of presentation

Secondary Outcomes (1)

  • Identification of sepsis based on Sepsis-3 criteria

    Within 4 hours of presentation

Interventions

Tests will be run to determine early identification of sepsis and added value of the combination of tests. Results will not be used to manage patients

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All adults with suspicion of infection who present to the Emergency Department and for whom a CBC-DIFF is ordered upon presentation

You may qualify if:

  • CBC-DIFF upon presentation
  • Adults (18-89) of all races \& ethnicities
  • Signed Informed Consent

You may not qualify if:

  • Previously enrolled
  • Incomplete Informed Consent
  • Subject discharged \<4 hours from presentation
  • PCT or CRP not performed per protocol
  • Pregnancy
  • Prisoners
  • Subjects Under Custody or Guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

La Pitié-Salpétrière

Paris, 75651, France

Location

Hospital Universitari Germans Trias I Pujol

Badalona, 08910, Spain

Location

Related Publications (1)

  • Hausfater P, Robert Boter N, Morales Indiano C, Cancella de Abreu M, Marin AM, Pernet J, Quesada D, Castro I, Careaga D, Arock M, Tejidor L, Velly L. Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study. Crit Care. 2021 Jun 30;25(1):227. doi: 10.1186/s13054-021-03622-5.

Biospecimen

Retention: SAMPLES WITHOUT DNA

plasma samples from LPS to be stored frozen for subsequent testing for sepsis biomarkers

MeSH Terms

Conditions

InfectionsSepsis

Condition Hierarchy (Ancestors)

Systemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Pierre Hausfater, MD

    Groupe Hospitalier Pitié-Salpêtrière

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2018

First Posted

July 17, 2018

Study Start

August 8, 2018

Primary Completion

August 2, 2019

Study Completion

August 30, 2019

Last Updated

November 22, 2019

Record last verified: 2019-11

Locations